Belkyra (sodium deoxycholate)receives first European positive opinion via decentralised procedure to treat subliminal fat.- Allergan
Allergan has announced that it has received a Positive Opinion from the Swedish Medical Products Agency (MPA) for Belkyra (deoxycholic acid), for the treatment of moderate to severe convexity or fullness associated with submental fat (often called double chin) in adults when the presence of submental fat has a psychological impact for the patient. Belkyra is being evaluated through the Decentralised Procedure, with the Swedish MPA acting as the Reference Member State for 20 other countries in the European Union, as well as Iceland and Norway .
Comment: Sodium deoxycholate as Kybella was approved by the FDA in April 2015, for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins